Literature DB >> 15506969

Sab (SH3BP5), a novel mitochondria-localized JNK-interacting protein.

C Wiltshire1, D A F Gillespie, G H W May.   

Abstract

The JNK (c-Jun N-terminal kinase) pathway is activated by diverse stresses and can have an effect on a number of different cellular processes. Protein-protein interactions are critical for efficient signalling from JNK to multiple targets; through a screen for interacting proteins, we identified a novel JNK-interacting protein, Sab (SH3BP5). Sab has previously been found to interact with the Src homology 3 domain of Bruton's tyrosine kinase; however, the interaction with JNK occurs through a mitogen-activated protein KIM (kinase interaction motif) in a region distinct from the Bruton's tyrosine kinase-binding domain. As with c-Jun, the presence of this KIM is essential for Sab to act as a JNK substrate. Interestingly, Sab is associated with the mitochondria and co-localizes with a portion of active JNK after stress treatment. The present study and previously reported work may suggest a possible role for Sab in targeting JNK to this subcellular compartment and/or mediating crosstalk between different signal-transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506969     DOI: 10.1042/BST0321075

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  17 in total

1.  Transient anoxia and oxyradicals induce a region-specific activation of MAPKs in the embryonic heart.

Authors:  Stephany Gardier; Sarah Pedretti; Alexandre Sarre; Eric Raddatz
Journal:  Mol Cell Biochem       Date:  2010-03-21       Impact factor: 3.396

Review 2.  Network Motifs in JNK Signaling.

Authors:  Vasudha Sehgal; Prahlad T Ram
Journal:  Genes Cancer       Date:  2013-09

3.  Modulation of the c-Jun N-terminal kinase activity in the embryonic heart in response to anoxia-reoxygenation: involvement of the Ca2+ and mitoKATP channels.

Authors:  Alexandre Sarre; Stéphany Gardier; Fabienne Maurer; Christophe Bonny; Eric Raddatz
Journal:  Mol Cell Biochem       Date:  2008-04-17       Impact factor: 3.396

4.  Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1).

Authors:  Jeremy W Chambers; Lisa Cherry; John D Laughlin; Mariana Figuera-Losada; Philip V Lograsso
Journal:  ACS Chem Biol       Date:  2011-05-24       Impact factor: 5.100

Review 5.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

6.  Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation.

Authors:  Jeremy W Chambers; Philip V LoGrasso
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

7.  Improvement of liver injury and survival by JNK2 and iNOS deficiency in liver transplants from cardiac death mice.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  J Hepatol       Date:  2015-02-19       Impact factor: 25.083

8.  c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice.

Authors:  Sanda Win; Tin Aung Than; Derick Han; Lydia M Petrovic; Neil Kaplowitz
Journal:  J Biol Chem       Date:  2011-08-15       Impact factor: 5.157

9.  SH3-binding protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase.

Authors:  Yuji Takeshita; Yuichi Hashimoto; Mikiro Nawa; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

10.  Insulin signaling regulates mitochondrial function in pancreatic beta-cells.

Authors:  Siming Liu; Terumasa Okada; Anke Assmann; Jamie Soto; Chong Wee Liew; Heiko Bugger; Orian S Shirihai; E Dale Abel; Rohit N Kulkarni
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.